2022 Shingles in Australia Webinar
About the Webinar
This webinar provided an update on shingles epidemiology and current trends in vaccination rates.
Low shingles vaccination rates in Australian adults impact the epidemiology of the disease. This webinar explores what current guidelines advise regarding improving shingles vaccination rates in Australia, and therefore reducing disease burden and complications.
It discusses the two shingles vaccinations available in Australia, comparing efficacy, safety, dosage regimens and indications for each vaccine.
Learning Outcomes:
- Describe the epidemiology of shingles in various population groups, including persons aged over 65 years
- Outline current vaccination rates in older Australians, and recognised strategies for improving uptake of shingles vaccines
- Explain the possible clinical sequelae associated with shingles, including serious complications, impact on quality of life, and the particular risk attributed to persons aged over 80 years.
- Identify the patients in whom shingles vaccination is a priority, based on age and medical comorbidities.
- Describe and compare the two shingles vaccines currently available in Australia, including safety profiles, efficacy, dosage regimens and costs.
Presented by Angela Newbound
Видео 2022 Shingles in Australia Webinar канала Immunisation Coalition
This webinar provided an update on shingles epidemiology and current trends in vaccination rates.
Low shingles vaccination rates in Australian adults impact the epidemiology of the disease. This webinar explores what current guidelines advise regarding improving shingles vaccination rates in Australia, and therefore reducing disease burden and complications.
It discusses the two shingles vaccinations available in Australia, comparing efficacy, safety, dosage regimens and indications for each vaccine.
Learning Outcomes:
- Describe the epidemiology of shingles in various population groups, including persons aged over 65 years
- Outline current vaccination rates in older Australians, and recognised strategies for improving uptake of shingles vaccines
- Explain the possible clinical sequelae associated with shingles, including serious complications, impact on quality of life, and the particular risk attributed to persons aged over 80 years.
- Identify the patients in whom shingles vaccination is a priority, based on age and medical comorbidities.
- Describe and compare the two shingles vaccines currently available in Australia, including safety profiles, efficacy, dosage regimens and costs.
Presented by Angela Newbound
Видео 2022 Shingles in Australia Webinar канала Immunisation Coalition
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Determining risk factors and benefits of vaccination: a guide to immunisers - Dr Hazel ClothierInfluenza / COVID-19 / RSV Webinar Series - Webinar 1What hesitant people should knowWhat should you do when there is an imminent risk of COVID in your community?Pneumococcal Disease - Paul Van Buynder - Adult Immunisation Forum 2023Immunisation Coalition: 2021 Influenza Vaccination Webinar2022 Art Prize - Enter NOW!UK Primary Care response to COVID-19 - Prof Richard HobbsRecent pandemics and informed predictions - Prof Stanley PerlmanAnnual Scientific Meeting 2023 - Long COVID-19: A Brief OverviewThe way we were - Peter Doherty at 2018 ISG Annual Scientific MeetingWhat hesitant people should know about COVID-19What are the common side effects of COVID vaccination?Vaccine catch up - Lynne Addlem2024 Pertussis WebinarNew technology vaccines: Safety and efficacy - Prof Margie DanchinWill booster doses be required?Meningococcal vaccines for AdolescentsSafety First the Influenza Vacation Is like a Seatbelt2023 Pertussis Webinar